EU Warns Novo's Ozempic May Cause Rare Serious Eye Disorders
TL;DR Summary
The European Medicines Agency has confirmed that Novo Nordisk's drugs Ozempic and Wegovy, containing semaglutide, may very rarely cause a serious eye condition leading to vision loss, affecting up to 1 in 10,000 users, prompting updates to drug labels while maintaining the drugs' overall benefit-risk profile.
Reading Insights
Total Reads
0
Unique Readers
17
Time Saved
2 min
vs 3 min read
Condensed
89%
424 → 46 words
Want the full story? Read the original article
Read on KSL News